These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 11211421)
1. Peyote use during pregnancy. Gilmore HT S D J Med; 2001 Jan; 54(1):27-9. PubMed ID: 11211421 [TBL] [Abstract][Full Text] [Related]
2. Hallucinogens and redemption. de Rios MD; Grob CS; Baker JR J Psychoactive Drugs; 2002; 34(3):239-48. PubMed ID: 12422934 [TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to anti-epileptic drugs: the need for preconception counselling. Shallcross R; Winterbottom J; Bromley R Pract Midwife; 2011 Dec; 14(11):20-1. PubMed ID: 22216583 [TBL] [Abstract][Full Text] [Related]
4. Teratogenic risks from exposure to illicit drugs. Holbrook BD; Rayburn WF Obstet Gynecol Clin North Am; 2014 Jun; 41(2):229-39. PubMed ID: 24845487 [TBL] [Abstract][Full Text] [Related]
5. Examination of Recreational and Spiritual Peyote Use Among American Indian Youth. Prince MA; O'Donnell MB; Stanley LR; Swaim RC J Stud Alcohol Drugs; 2019 May; 80(3):366-370. PubMed ID: 31250802 [TBL] [Abstract][Full Text] [Related]
6. Psychological and cognitive effects of long-term peyote use among Native Americans. Halpern JH; Sherwood AR; Hudson JI; Yurgelun-Todd D; Pope HG Biol Psychiatry; 2005 Oct; 58(8):624-31. PubMed ID: 16271313 [TBL] [Abstract][Full Text] [Related]
7. GC-MS and GC-MS/MS in PCI mode determination of mescaline in peyote tea and in biological matrices. Gambelunghe C; Marsili R; Aroni K; Bacci M; Rossi R J Forensic Sci; 2013 Jan; 58(1):270-8. PubMed ID: 22900815 [TBL] [Abstract][Full Text] [Related]
8. Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca. Winkelman M Curr Drug Abuse Rev; 2014; 7(2):101-16. PubMed ID: 25563446 [TBL] [Abstract][Full Text] [Related]
10. [Gynecological-obstetrical problems in female drug users and drug addicts]. Zumbé FJ; Beck KJ; Schönhöfer PS Geburtshilfe Frauenheilkd; 1973 Apr; 33(4):241-53. PubMed ID: 4710014 [No Abstract] [Full Text] [Related]
11. [Experimental intoxication by mescaline. 1948]. Delay J; Gérard HP Encephale; 2007 Jun; 33 Spec No 2():S455-79. PubMed ID: 17941270 [No Abstract] [Full Text] [Related]
12. [The local and general teratogenic effects of soft and hard drugs on the neonate]. Mirra M Arch Stomatol (Napoli); 1988 Nov; 29(5):1127-40. PubMed ID: 3272569 [No Abstract] [Full Text] [Related]
13. Ensuring the safe and effective use of medications during pregnancy: planning and prevention through preconception care. Cragan JD; Friedman JM; Holmes LB; Uhl K; Green NS; Riley L Matern Child Health J; 2006 Sep; 10(5 Suppl):S129-35. PubMed ID: 16850277 [No Abstract] [Full Text] [Related]
14. Risk minimization practices for pregnancy prevention: understanding risk, selecting tools. Uhl K; Trontell A; Kennedy D Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):337-48. PubMed ID: 16953517 [TBL] [Abstract][Full Text] [Related]
15. Peyote and mescaline exposures: a 12-year review of a statewide poison center database. Carstairs SD; Cantrell FL Clin Toxicol (Phila); 2010 May; 48(4):350-3. PubMed ID: 20170392 [TBL] [Abstract][Full Text] [Related]
16. Blood flow and cerebral laterality in the mescaline model of psychosis. Hermle L; Gouzoulis-Mayfrank E; Spitzer M Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():85-91. PubMed ID: 9754839 [TBL] [Abstract][Full Text] [Related]
17. Sodium valproate and the fetus: a case study and review of the literature. Smith J; Whitehall J Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633 [TBL] [Abstract][Full Text] [Related]
18. Prescribing in pregnancy and during breast feeding: using principles in clinical practice. Henderson E; Mackillop L Postgrad Med J; 2011 May; 87(1027):349-54. PubMed ID: 21273359 [TBL] [Abstract][Full Text] [Related]
19. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Ornoy A Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988 [TBL] [Abstract][Full Text] [Related]
20. Functional teratogenic effects of chemicals on the developing brain. Swaab DF; Mirmiran M Monogr Neural Sci; 1986; 12():45-57. PubMed ID: 3796647 [No Abstract] [Full Text] [Related] [Next] [New Search]